Physician profile
Michael Hoosien
NPI 1134362627
$37,273.48
in general payments reported to CMS, 2019-2025
34 companies · $3,667 in 2025
The $3,667 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $5,610 · 2021: $5,340 · 2022: $3,022 · 2023: $2,262 · 2024: $5,986 · 2025: $3,667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,507 · Travel and Lodging: $3,534 · Consulting Fee: $1,874.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,507.37 |
| Travel and Lodging | $3,533.58 |
| Consulting Fee | $1,874.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $15,227.45 | 2019-2024 | Xarelto |
| Biosense Webster, INC. | $6,360.62 | 2019-2025 | Carto 3, Qdot Micro Catheter, Octaray Mapping Catheter |
| Atricure, INC. | $3,540.93 | 2021-2025 | Epi-Sense Guided Coagulation System With Visitrax, Epi-Ease Epicardial Access System |
| Medtronic, INC. | $3,216.51 | 2021-2025 | Sphere-9, Affera Mapping System, Pulseselect |
| Cvrx, INC. | $2,808.52 | 2020-2025 | Barostim Neo System |
| Biotronik INC. | $1,849.82 | 2024 | Biomonitor, Acticor 7 Vr-T Dx, Solia |
| Abbott Laboratories | $1,034.58 | 2019-2025 | Aveir, Ensite, Jot Dx |
| Boston Scientific Corporation | $921.47 | 2019-2025 | Watchman Access System, Farawave, Fineline II Sterox |
| Ebr Systems, INC. | $535.81 | 2025 | |
| Cardiva Medical, INC. | $244.98 | 2022-2024 | Cardiva Vascade Mvp Vvcs 6-12f, Ensoetm |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $219.94 | 2019-2025 | Lifevest |
| Medtronic Vascular, INC. | $196.50 | 2019-2020 | |
| Zoll Respicardia, INC. | $165.53 | 2024 | Remede System |
| Acutus Medical, INC. | $159.74 | 2022-2023 | |
| Cordis US Corp. | $91.79 | 2024-2025 | Mynx Control, Mynx Control Venous, Mynx Venous Vcd |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $91.15 | 2021-2025 | Eliquis, Camzyos |
| Impulse Dynamics (USA) INC. | $91.07 | 2019-2024 | Optimizer, Optimizer |
| Inspire Medical Systems, INC. | $81.02 | 2024-2025 | Inspire |
| Edwards Lifesciences Corporation | $66.72 | 2023-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Pfizer INC. | $42.47 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $42.33 | 2019-2023 | |
| Portola Pharmaceuticals, LLC | $40.37 | 2019 | |
| Baxter Healthcare | $34.17 | 2025 | |
| Novartis Pharmaceuticals Corporation | $32.26 | 2024-2025 | |
| Philips North America LLC | $26.55 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $24.75 | 2023 | Andexxa |
| Vektor Medical INC. | $24.03 | 2025 | Vmap |
| Esperion Therapeutics, INC. | $22.39 | 2025 | Nexletol |
| Cardiofocus, INC. | $18.27 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.79 | 2021 | |
| Irhythm Technologies, INC. | $15.72 | 2023 | Zio Xt Patch |
| Amgen INC. | $14.42 | 2024 | Repatha |
| Merck Sharp & Dohme LLC | $13.81 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hoosien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.